Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
RedHill Biopharma Ltd.

RedHill Biopharma Ltd. (RDHL) Stock Overview

Explore RedHill Biopharma Ltd.’s financial performance, market position, analyst ratings, and future outlook.

RDHL●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.59
$0.01(1.98%)
U.S. Market is Open · 13:57

RedHill Biopharma Ltd. (RDHL)

Meyka AI Score

Z

Key Financials

Market Cap1.9M
P/E Ratio-0.30
EPS (TTM)$5.00
ROE57.40%
Fundamental Analysis

AI Price Forecasts

1 Month$0.72
3 Months$1.02
1 Year Target$0.00

RDHL Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of RedHill Biopharma Ltd. (NASDAQ: RDHL) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, RedHill Biopharma Ltd.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of RDHL on the NASDAQ shows an RSI of 36.90, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind RedHill Biopharma Ltd.'s NASDAQ-traded stock include a P/E ratio of -0.30 and a market capitalization of 1.9M. Combined with our AI analysis, these give both institutional and retail investors a clear view of RDHL on the NASDAQ.

Price Performance (NASDAQ: RDHL)

1-Day Change
-1.50%
5-Day Change
-8.80%
1-Month Change
-14.96%
3-Month Change
-42.06%
6-Month Change
-40.01%
Year-to-Date (YTD) Change
-42.62%
1-Year Change
-55.56%
3-Year Change
-97.23%
5-Year Change
-99.99%
All-Time (Max) Change
-99.99%

Contact Information

https://www.redhillbio.com
972 3 541 3131
21 Ha’arba’a Street, Tel Aviv, TA, 6473921

Company Facts

130 Employees
IPO DateJan 7, 2013
CountryIL
Actively Trading

Frequently Asked Questions